138842-45-2

138847-29-7 9,10-Anthracenedione, 1,3,8-trihydroxy-2-(1-hydroxyhexyl)-6-methoxy-,(S)-

138846-90-9 2,4-Hexadiene-1,6-diimine

1419075-90-3 SC1126

141911-69-5 transcription factor my1

138843-17-1 1-Hexatetraconten-15-one, 37-(acetyloxy)-

138846-92-1 2H-1,5-Benzodioxepin-2-one, 3,4-dihydro-4-phenyl-

141909-47-9 DES (1-6) IGF II

141912-84-7 7-(2-(2-amino-5-chlorothiazol-4-yl)-2-methoxyiminoacetamido)-3-(imidazo(1,5-a)-pyridinium-1-yl)methyl-3-cephem-4-carboxylate

141898-45-5 Methanediylium, phenyl-

141898-80-8 Benzene,chloromethyl-,mixt. with tetrachloroethene (1:1)

138847-08-2 Pyrrolidinium,1-(2-methyl-2-propenyl)-1-[3-(1-naphthalenyl)-2-propynyl]-, chloride

138848-23-4 Phosphonic acid, [3-(diphenylphosphinyl)-2-hydroxyphenyl]-, diethylester

138845-13-3 Diazene, [4-[(6-bromohexyl)oxy]phenyl](4-methylphenyl)-, (E)-

138845-17-7 Ethanamine, phosphonate (1:1)

138845-31-5 Methanol, [methyl[4-[2-(4-nitrophenyl)ethenyl]phenyl]amino]-

141910-80-7 Gendevit

141901-74-8 4-trifluoromethylphenyl-2-biphenylyl-3-hydroxypropionic acid

141902-99-0 2(3H)-Furanone,3-acetyldihydro-3-hydroxy-4-methyl-, (3S,4R)-

141911-75-3 CAf1M protein

14190-40-0 1-Cyano-N-(2-fluorophenyl)thioformamide